Skip to content

Clinical trials

Multiple Sclerosis, Relapsing-Remitting trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Country / region: France Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20042
20063
20076
20085
20097
20102
20112
20123
20136
20145
20162
20176
20181
20196
20205
20211
20223
20232
20242
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53
Terminated12
Active, not recruiting5
Not yet recruiting4
Recruiting4
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen18
Bayer7
Hoffmann-La Roche5
Rennes University Hospital5
Genzyme, a Sanofi Company4
Nantes University Hospital4
University Hospital, Strasbourg, France4
Assistance Publique - Hôpitaux de Paris3
University Hospital, Caen3
University Hospital, Montpellier3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting82
Multiple Sclerosis41
Multiple Sclerosis, Chronic Progressive7
Recurrence6
Autoimmune Diseases3
Cognitive Dysfunction3
Demyelinating Diseases3
Nervous System Diseases3
Immune System Diseases2
Inflammation2

Trials

Showing 26 to 50 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.